Health professionals' knowledge, attitude and practices towards pharmacovigilance in Nepal;Conocimientos, actitudes Y prácticas de los profesionales de la salud hacia la farmacovigilancia en Nepal

Pharmacy Practice

Volumn 9, Issue 4, 2011, Pages 228-235

  Palaian, Subish ^a   Ibrahim, Mohamed I ^b   Mishra, Pranaya ^c  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b QASSIM UNIVERSITY   (Saudi Arabia)

^c Department of Pharmacology ^*  (Netherlands)

Author keywords

Adverse drug reaction reporting systems; Attitude of health personnel; Nepal

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH PERSONNEL ATTITUDE; HEALTH PRACTITIONER; HUMAN; KNOWLEDGE; MALE; NEPAL; NURSE; PHARMACIST; PHYSICIAN; PROFESSIONAL PRACTICE; TEACHING HOSPITAL;

EID: 83655164353     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552011000400008     Document Type: Article

References (38)

1. Beard K Adverse reactions as a cause of hospital admission in the aged. Drugs Aging. 1992;2(4):356-367.
2. Murphy BM, Frigo LC. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital. Hosp Pharm. 1993;28(12):1199-204,1240.
3. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-1205.
4. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277(4):301-306
5. Anonymous. Safety monitoring of medicinal products. The importance of pharmacovigilance. World Health Organization, Geneva, 2002.
6. Li, Q, Zhang SM, Chen HT, Fang SP, Yu X, Liu D, Shi LY, Zeng FD. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J (Engl). 2004;117:856-861.
7. Meyboom R, Olsson S, Thorogood M. Teaching pharmacovigilance, In: Pharmacovigilance R.D. Mann, E.B. Andrews, (ed)., John Wiley and Sons, 2002, p.505-508.
8. Anonymous. Safety of Medicines. A guide to detecting and reporting adverse drug reactions, WHO, Geneva, 2002.
9. Hartigan-Go K. Pharmacovigilance and the pursuit of rational drug use: The Philippines experience. Uppsala Reports. 2001;(14 S):1-4.
10. Lee A, Thomas SHL. Adverse drug reactions In: Walker R and Edward C. Clinical pharmacy and Therapeutics. 3rd edition Churchill Livingstone, 2003, p.33-46.
11. Hughes ML, Whittlesea CM, Luscombe DK. Review of national spontaneous reporting schemes. Strengths and weaknesses. Adverse Drug React Toxicol Rev. 2002;21(4):231-241.
12. Anonymous. Validating vigibase online. Uppsala Reports. 2006;(32):10-11.
13. Faich GA. Adverse-drug-reaction monitoring. N Engl J Med. 1986;314(24):1589-1592.
14. Eisenhauer LA. Adverse drug reactions: a concern for clinicians and patients. Clin Excell Nurse Pract. 2002;6:3-7.
15. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Health Syst Pharm. 1995;52(4):417-419
16. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385-396.
17. Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong. Ann Pharmacother. 1994;28(12):1400-1403.
18. Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf. 2007;16(2):223-228.
19. Herdeiro MT, Figueiras A, Polónia J, Gestal-Otero JJ. Physicians' attitudes and adverse drug reaction reporting: a case- control study in Portugal. Drug Saf. 2005;28(9):825-833.
20. Okezie E O, Olufunmilayo F. Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf. 2008;17(5):517-522.
21. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32(1):19-31.
22. Subish P, Mohamed Izham MI, Mishra P. Evaluation of the knowledge, attitude and practices on adverse drug reactions and pharmacovigilance among healthcare professionals in a Nepalese hospital-a preliminary study. Internet Journal of Pharmacology 2008;6:1
23. Olsson S. The need for pharmacovigilance In: Gupta SK. Pharmacology and therapeutics in the new millennium. Narosa publishing house, New Delhi, 2001, p.502-508.
24. Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, Hernández-Díaz S, Lasheras B. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf. 2007; 30(11):1073-82.
25. Belton K J, Lewis SC, Payne S, Rawlins MD, Wood SM.Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol. 1995;39(3):223-326.
26. Rehan HS, Vasudev K, Tripathi CD. Adverse drug reaction monitoring: knowledge, attitude and practices of medical students and prescribers. Natl Med J India. 2002;15(1):24-26.
27. Graille V, Lapeyre-Mestre M, Montastruc JL. Drug vigilance: opinion survey among residents of a university hospital. Therapie. 1994;49(5):451-454.
28. Cosentino M, Leoni O, Banfi, F, Leechini S, Frigo G. Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district. Pharmacol Res. 1997;35(2):85-8.
29. Bharathan B, Raju, N. A survey about the knowledge, attitude and practice of adverse drug reaction reporting among doctors in Bangalore city. Sixth annual conference of the Society of Pharmacovigilance (India), Kurupanidhi College of Pharmacy, Bangalore, India, 2006.
30. Subish P, Izham M, Mishra P. Pharmacovigilance in Nepal. A guide for healthcare professionals. Regional Pharmacovigilance Centre, Pokhara, Nepal, 2007.
31. Belton K J. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group. Eur J Clin Pharmacol. 1997;52(6):423-427.
32. Eland IA, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BH. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48(4):623-627.
33. Holland EG, Degruy FV. Drug-Induced Disorders. Am Fam Physician. 1997;56(7):1781-1792.
34. Shankar PR, Mishra P, Subish, P, Upadhyay DK. The drug information center at the Manipal teaching hospital- going beyond drug information. Drug Inform J. 2007;41:61-68.
35. Subish P, Mishra P, Shankar PR, Bista D, Purwar B. Contribution of the regional drug information center towards drug safety. JNMA J Nepal Med Assoc. 2006;45(161):216-218.
36. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245.
37. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49(9):2229-2232.
38. Shankar PR, Subish P, Mishra P, Dubey, AK. Teaching pharmacovigilance to medical students and doctors. Ind J Pharmacol. 2006;38:316-319.